(Toronto, November 11, 2024) A new study published in the Journal of Medical Internet Research by JMIR Publications reveals promising results from a digital health intervention that is based on a decade of research at Harvard Medical School and designed to alleviate depressive symptoms. The study, titled "Facilitating Thought Progression to Reduce Depressive Symptoms: Randomized Controlled Trial," found that participants experienced substantial reduction of depressive symptoms by using a gamified mobile app focused on disrupting ruminative thinking.
Led by Prof. Moshe Bar and colleagues, the research focused on a new gamified approach to target ruminative thinking—a major contributor to depression. The app used in this study includes 5 mini-games designed to help users break negative thought cycles, encouraging flexible thought progression.
Over the 8-week randomized controlled trial, conducted at the Massachusetts General Hospital, participants using the app showed faster and more substantial symptom improvement than those not using the app, based on weekly clinician evaluations throughout the study. Additionally, the positive effects of using the app were still evident up to 4 weeks after the study ended, indicating the potential long-lasting impact of the app.
“After demonstrating in the laboratory the striking effect of facilitating thought progression on mood, we now reveal that implementing this neuroscience-based approach in a digital app can provide a most viable path for the alleviation of depression symptoms,” reported Prof. Moshe Bar.
This study shows that a gamified app can offer a unique and potent way to break negative thought cycles by facilitating the progression of thought. By implementing effective therapy that is both engaging and accessible, this science-based gamified approach can complement traditional treatment methods for depression.
Original article:
Yatziv S, Pedrelli P, Baror S, DeCaro S, Shachar N, Sofer B, Hull S, Curtiss J, Bar M. Facilitating Thought Progression to Reduce Depressive Symptoms: Randomized Controlled Trial. J Med Internet Res 2024;26:e56201
URL: https://www.jmir.org/2024/1/e56201. DOI: 10.2196/56201
###
About JMIR Publications:
JMIR Publications, celebrating its 25th anniversary in 2024, is a leading open access digital health research publisher. As a pioneer in open access publishing, JMIR Publications is committed to driving innovation in scholarly communications, advancing digital health research, and promoting open science principles. Our portfolio features 35 open access, peer-reviewed journals dedicated to the dissemination of high-quality research in the field of digital health, including the Journal of Medical Internet Research, as well as cross-disciplinary journals such as JMIR Research Protocols and the new title JMIR XR & Spatial Computing.
To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media contact: communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
Journal
Journal of Medical Internet Research
DOI
Method of Research
Randomized controlled/clinical trial
Subject of Research
People
Article Title
Facilitating Thought Progression to Reduce Depressive Symptoms: Randomized Controlled Trial
Article Publication Date
7-Nov-2024
COI Statement
none declared